News

PMDA received an application for a clinical trial for the IND package of GAIA-102 i.v.

New Funding by AMED for a Clinical Trial of GAIA-102 to Treat Malignant Ascites

Our President & CEO Kazu Kuramori was at the Innate Killer Summit 2019 – Title：GAIA-102 as an NK Cell-Based “Upward Compatible” Modality Over CAR-T-Cell Therapy –

GAIA BioMedicine has released an experimental kit to produce highly activated NK-like cells for research use